Limonium vulgare Mill. is a plant growing widely in harsh environments, such as salt marshes, for which a chemical profile is still unknown, although some interesting bioactivities were already reported. So, this halophyte chemical profile must be established to find the possible bioactive compounds, valorize the species, and contribute to the salt marsh’s exploitation. This work set the chemical profile of L. vulgare’s aerial parts (leaves and inflorescences) using UHPLC-DAD-ESI/MS2 and GC-MS analysis. The lipophilic profile showed a richness in fatty acids, alkanes, and terpenoids, β-sitosterol being the major compound in inflorescences in the fruiting stage (0.822 ± 0.015 mg/g of the dry plant) and leaves (0.534 ± 0.017 mg/g of the dry plant). In contrast, in the inflorescences in the flowering stage, the major compound is nonacosane (0.228 ± 0.001 mg/g of the dry plant). The polyphenolic profile demonstrates that L. vulgare produces several flavonoids from which quercetin and myricetin can be highlighted; in particular, myricetin derivatives are prevalent in all extracts. Amongst the flavonoids, myricetin 3-rhamnoside is the most abundant in the inflorescences in the flowering stage (6.35 ± 0.05 mg/g of the dry plant), myricetin in leaves (9.69 ± 0.11 mg/g of the dry plant), and in the inflorescences in the fruiting stage baicalin presents the highest amount (5.15 ± 0.07 mg/g of the dry plant). This is the first report on L. vulgare’s chemical profile and the results indicate that this species is an exciting source of bioactive compounds, suggesting it has a use to produce nutraceuticals and/or pharmaceuticals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.